Anmeldung erfolgt in Kürze...
Details werden geladen...
EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027 | 19.10.26 | finanzen.ch
EQS-Ad-hoc: Pentixapharm Holding AG / Key word(s): Forecast / Full year Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enr...
Ähnliche Seiten
EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027 | 19.10.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/eqs-adhoc-pentixapharm-holding-ag-2026-earnings-guidance-raised;-first-patient-enrollment-in-panda-phase-3-study-now-expected-in-the-first-quarter-of-2027-1036640851
EQS-Adhoc: Pentixapharm Holding AG: Ergebnisprognose 2026 angehoben; Aufnahme des ersten Patienten in PANDA Phase-3-Studie nunmehr für das erste Quartal 2027 erwartet | 19.10.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/eqs-adhoc-pentixapharm-holding-ag-ergebnisprognose-2026-angehoben;-aufnahme-des-ersten-patienten-in-panda-phase-3-studie-nunmehr-fuer-das-erste-quartal-2027-erwartet-1036640850EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance | 16.10.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/eqs-adhoc-dhl-ag-dhl-ag-raises-full-year-2026-earnings-guidance-1036635025EQS-Adhoc: Bio-Gate AG: Revises Revenue and Earnings Forecast for Fiscal Year 2026 | 06.10.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/eqs-adhoc-bio-gate-ag-revises-revenue-and-earnings-forecast-for-fiscal-year-2026-1036601490EQS-Adhoc: Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance | 13.10.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/eqs-adhoc-ad-hoc-evotec-announces-preliminary-nine-months-2026-results-above-market-expectations-reaffirming-full-year-2026-guidance-1036622724